Malignant Eye Neoplasm — Trials

Malignant Eye Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

446 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 83
Recruiting: 44
Ph III recruiting: 10
Growth YoY: —
Industry share: 30%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01906814	Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation	unknown	Phase 3	179	Sun Yat-sen UniversityOTHER	1	Apr 9, 2024	clinicaltrials
NCT02137928	Carboplatin Periocular Injection for Retinoblastoma	unknown	Phase 3	50	Sun Yat-sen UniversityOTHER	1	Dec 19, 2014	clinicaltrials
NCT00811200